Marker Therapeutics Other Operating Expenses (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.57 +0.02 (+1.29%) USD | NASDAQ | Feb 26, 15:54

View Other Operating Expenses (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--